Skip to main content
SpringerLink
Log in

Aspects endocriniens de la fatigue chronique

  • Chapter
Syndrome de Fatigue Chronique / Chronic Fatigue Syndrome

  • 48 Accesses

Résumé

La fatigue, sous ses formes neuropsychique ou neuromusculaire, est une composante sémiologique de nombreuses pathologies. L’experience clinique des maladies endocriniennes permet de retenir le rôle de perturbations hormonales dans sa constitution. Différents mécanismes physiopathologiques hormonodépendants sont impliqués, tant au niveau musculaire qu’au plan du système nerveux central pour concourir à la fatigue. Inversement, la fatigue chronique de nature endogène telle qu’observée dans les états dépressifs est à l’origine de modifications neuro-endocriniennes, confirmant ainsi l’étroite intrication des processus. La boucle d’interdépendance entre les désordres endocriniens et l’état de fatigue chronique conduit à envisager la possibilité de terrains propices à l’installation d’un tel cercle vicieux. L’approche génétique et l’analyse moléculaire de la biochimie cellulaire peuvent s’avérer des voies nouvelles pour appréhender la fatigue sur un mode uniciste plutôt qu’à travers ses différents aspects sectoriels attachés à un organe ou à un appareil.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliographie

  1. Apa (1987) Task force on laboratory tests in psychiatry: the dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psych 144: 1253–1262

    Google Scholar 

  2. Argemi B, Vagneur JP (1982) Hypoparathyroïdies. In: Encycl Med Chir Paris, Glandes, 3: 10012A10

    Google Scholar 

  3. Ballinger B (1975) Psychiatric morbidity and the menopause; screening of general population sample. Br Med J 3: 344–346

    Article  Google Scholar 

  4. Beetham WP Jr (1979) Diagnostic and management of fibrositis syndrome and psychogenic rheumatism. Med Clin North Am 63: 433–439

    Google Scholar 

  5. Berger M, Berchtold P, Cuppers HJ, Drost H, Kley MK, Muller WA, Weigelmann W, Zimmermann-Telscow H, Gries FA, Krus-Kemper HL, Zimmermann H (1977) Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia 13: 355–365

    Article  Google Scholar 

  6. Brown WA, Shrivastava R, Arato M (1987) Pretreatment pituitary-adrenocortical status and placebo response in depression. Psychopharmacol Bull 23: 155–159

    Google Scholar 

  7. Carpenter WT, Bunney WE (1971) Adrenal cortical activity in depressive illness. Am J Psych 128: 31–40

    Google Scholar 

  8. Charney DS, Heninger GR, Sternberg DE (1982) Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and healthy controls. Arch Gen Psych 39: 290–294

    Google Scholar 

  9. Checkley SA (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10: 35–53

    Article  Google Scholar 

  10. Corn TH, Hale AS, Thompson C (1984) A comparison of the growth hormone responses to clonidine and apomorphine in the same patients with endogenous depression. Br J Psych 144: 636–639

    Article  Google Scholar 

  11. England JA, Gerhard DS, Pauls DL (1987) Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325: 783–787

    Article  Google Scholar 

  12. Felig P, Wahren J (1975) Fuel homeostasis in exercise. N Engl J Med 293: 1078–1084

    Article  Google Scholar 

  13. Hallbreich U, Grunhaus L, Ben-David M (1979) 24-hour rhythm of prolactin in depressive patients. Arch Gen Psych 36: 1183–1186

    Google Scholar 

  14. Hoch FL (1962) Thyrotoxicosis as a disease of mitochondria. N Engl J Med 266: 446–454

    Article  Google Scholar 

  15. Holloszy JO, Booth FW (1976) Biochemical adaptations to endurance exercise in muscles. Ann Rev Physiol 38: 273–291

    Article  Google Scholar 

  16. Holloszy JO, Constable SH, Young DA (1986) Activation of glucose transport in muscle by exercise. Diabetes/Metabolism Reviews 1: 409–423

    Article  Google Scholar 

  17. Holmes LJ, Storhin LH, Smythe GA (1989) Hypothalamic monoamines associated with the cephalic phase insulin response. Am J Physiol 256 (Endocrinol Metab 19): E236–E241

    Google Scholar 

  18. Kirkegaard C (1981) The thyrotropin response to thyrotropin-releasing hormone in endogenous depression. Psychoneuroendocrinology 6: 189–212

    Article  Google Scholar 

  19. Koivisto VA, De Fronzo RA (1984) Exercise in the treatment of type II diabetes. Acta Endocrinol 262 (suppl): 107–111

    Google Scholar 

  20. Koivisto V, Soman V, Conrad P, Hendler R, Nadel E, Felig P (1979) Insulin binding to monocytes in trained athletes: changes in the resting state and after exercise. J Clin Invest 64: 1011–1015

    Article  Google Scholar 

  21. Linquette M, Lefebvre J (1970) Considérations physiopathologiques et classification des insuffisances surrénales. Rev Prat 20: 1669–1681

    Google Scholar 

  22. Linquette M, Proye C, Cappoen JP (1975) Hyperparathyroïdies. In: Encycl Med Chir, Paris, Glandes, 2: 10012C10

    Google Scholar 

  23. Loosen PT, Prange AJ Jr (1983) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psych 140: 1145–1149

    Google Scholar 

  24. Lyngsoe J, Clausen JP, Trap-Jensen J, Sestoft L, Schaffalitzky de Muckadell O, Holst JJ, Nielsen SL, Rehfeld JF (1978) Exchange of metabolites in the leg of exercising juvenil diabetic subjects. Clin Sci 55: 73–80

    Google Scholar 

  25. Manu P, Lane TJ, Mathewos DA (1988) The frequency of the chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann Intern Med 109: 554–556

    Google Scholar 

  26. Mueckler M (1990) Family of glucose transporter genes. Implications for glucose homeostasis and diabetes. Diabetes 39: 6–11

    Article  Google Scholar 

  27. Nemmi R, Bottacchi E, Fazio R, Mamoli A, Corbo M, Camerlingo M, Galardi G, Erenbourg L, Canal N (1987) Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol 50: 1454–60

    Google Scholar 

  28. Rosenbaum AH, Maruta T, Schatzberg AF (1983) Toward a biochemical classification of depressive disorders VII: urinary free cortisol and urinary MHPG in depressions. Am J Psych 140: 314–318

    Google Scholar 

  29. Rothschild AJ (1988) Biology of depression. Med Clin North Am 72: 765–790

    Google Scholar 

  30. Sachar EJ, Hellman L, Rolfwarg HP (1973) Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psych 28: 19–24

    Google Scholar 

  31. Schambelan M, Slaton PE Jr, Biglieri EG (1971) Mineralocorticoid production in hyperadrenocorticism. Role in pathogenesis of hypokaliemic alkalosis. Am J Med 51: 299–303

    Article  Google Scholar 

  32. Schatzberg AF, Rothschild AJ, Langlais PJ (1985) A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psych Res 19: 57–64

    Article  Google Scholar 

  33. Sestoft L, Trap-Jensen J, Lyngsoe J, Clausen JP, Holst JJ, Nielsen SL, Rehfeld JF, Schaffalitzky de Muckadell O (1977) Regulation of gluconeogenesis and ketogenesis during rest and exercise in diabetic subjects and normal man. Clin Sci 53: 411–418

    Google Scholar 

  34. Suzuki I, Kono T (1980) Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 77: 2542–2545

    Article  Google Scholar 

  35. Tilbe K, Bell DA, McCain GA (1988) Loss of diurnal variation in serum cortisol, growth hormone and prolactin in patients with primary fibromyalgia. Arthritis Rheum 31: 99

    Article  Google Scholar 

  36. Vague J, Angeletti S (1982) La maladie périodique thyrotoxique. Sa place nosographique. Ann Endocrinol 43: 23–40

    Google Scholar 

  37. Vranic M, Kawamori R, Pek S, Kovacevic N, Wrenshall GA (1976) The essentiability of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs. J Clin Invest 57: 245–255

    Article  Google Scholar 

Download references

Authors
  1. J. Mirouze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Renard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinique des Maladies du Système Nerveux et de l’Appareil Locomoteur, Hôpital de la Timone, 1, chemin de l’Armée d’Afrique, 13005, Marsielle, France

    Georges Serratrice

  2. Service des Maladies Infectieuses et Tropicales, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri Huchard, 75877, Paris Cedex 18, France

    Jean-Louis Vildé

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Mirouze, J., Renard, E. (1991). Aspects endocriniens de la fatigue chronique. In: Serratrice, G., Vildé, JL. (eds) Syndrome de Fatigue Chronique / Chronic Fatigue Syndrome. Springer, Paris. https://doi.org/10.1007/978-2-8178-0868-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0868-0_8

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0870-3

  • Online ISBN: 978-2-8178-0868-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation